Clinical features and molecular bases of neuroacanthocytosis

Luca Rampoldi, Adrian Danek, Anthony P. Monaco

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

The term acanthocytosis is derived from the Greek for "thorn" and is used to describe a peculiar spiky appearance of erythrocytes. Acanthocytosis is found to be associated with at least three hereditary neurological disorders that are generally referred to as neuroacanthocytosis. Abetalipoproteinaemia is an autosomal recessive condition, characterised by absence of serum apolipoprotein B containing lipoproteins leading to fat intolerance and fat-soluble vitamin deficiency. This results in a progressive spinocerebellar ataxia with peripheral neuropathy and retinitis pigmentosa. Chorea-acanthocytosis is also an autosomal recessive condition and is characterised by chorea, orofaciolingual dyskinesia, dysphagia, dysarthria, areflexia, seizures and dementia. Some of its features, including choreic movements, peripheral neuropathy with areflexia, elevated serum creatine kinase levels and myopathy are shared by another form of neuroacanthocytosis, McLeod syndrome. Patients affected by this X-linked disorder also show abnormal expression of Kell blood group antigens and a permanent haemolytic state. In addition to these cases, acanthocytosis is occasionally associated with other neurological disorders, such as Hallervorden-Spatz disease. For each of the neuroacanthocytosis syndromes we review the main clinical features and their molecular bases. The recent molecular genetics findings are the first step towards the understanding of the pathogenetic mechanisms and eventually the search for effective treatments.

Original languageEnglish
Pages (from-to)475-491
Number of pages17
JournalJournal of Molecular Medicine
Volume80
Issue number8
DOIs
Publication statusPublished - 2002

Fingerprint

Neuroacanthocytosis
Abetalipoproteinemia
Chorea
Peripheral Nervous System Diseases
Nervous System Diseases
Pantothenate Kinase-Associated Neurodegeneration
Fats
Spinocerebellar Ataxias
Avitaminosis
Dysarthria
Retinitis Pigmentosa
Dyskinesias
Apolipoproteins B
Muscular Diseases
Creatine Kinase
Deglutition Disorders
Blood Group Antigens
Serum
Lipoproteins
Dementia

Keywords

  • Abetalipoproteinaemia
  • Acanthocytosis
  • Chorea
  • McLeod syndrome
  • Neuroacanthocytosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clinical features and molecular bases of neuroacanthocytosis. / Rampoldi, Luca; Danek, Adrian; Monaco, Anthony P.

In: Journal of Molecular Medicine, Vol. 80, No. 8, 2002, p. 475-491.

Research output: Contribution to journalArticle

Rampoldi, Luca ; Danek, Adrian ; Monaco, Anthony P. / Clinical features and molecular bases of neuroacanthocytosis. In: Journal of Molecular Medicine. 2002 ; Vol. 80, No. 8. pp. 475-491.
@article{aa72ce8c0d254fae8013402b4ad24ac7,
title = "Clinical features and molecular bases of neuroacanthocytosis",
abstract = "The term acanthocytosis is derived from the Greek for {"}thorn{"} and is used to describe a peculiar spiky appearance of erythrocytes. Acanthocytosis is found to be associated with at least three hereditary neurological disorders that are generally referred to as neuroacanthocytosis. Abetalipoproteinaemia is an autosomal recessive condition, characterised by absence of serum apolipoprotein B containing lipoproteins leading to fat intolerance and fat-soluble vitamin deficiency. This results in a progressive spinocerebellar ataxia with peripheral neuropathy and retinitis pigmentosa. Chorea-acanthocytosis is also an autosomal recessive condition and is characterised by chorea, orofaciolingual dyskinesia, dysphagia, dysarthria, areflexia, seizures and dementia. Some of its features, including choreic movements, peripheral neuropathy with areflexia, elevated serum creatine kinase levels and myopathy are shared by another form of neuroacanthocytosis, McLeod syndrome. Patients affected by this X-linked disorder also show abnormal expression of Kell blood group antigens and a permanent haemolytic state. In addition to these cases, acanthocytosis is occasionally associated with other neurological disorders, such as Hallervorden-Spatz disease. For each of the neuroacanthocytosis syndromes we review the main clinical features and their molecular bases. The recent molecular genetics findings are the first step towards the understanding of the pathogenetic mechanisms and eventually the search for effective treatments.",
keywords = "Abetalipoproteinaemia, Acanthocytosis, Chorea, McLeod syndrome, Neuroacanthocytosis",
author = "Luca Rampoldi and Adrian Danek and Monaco, {Anthony P.}",
year = "2002",
doi = "10.1007/s00109-002-0349-z",
language = "English",
volume = "80",
pages = "475--491",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Clinical features and molecular bases of neuroacanthocytosis

AU - Rampoldi, Luca

AU - Danek, Adrian

AU - Monaco, Anthony P.

PY - 2002

Y1 - 2002

N2 - The term acanthocytosis is derived from the Greek for "thorn" and is used to describe a peculiar spiky appearance of erythrocytes. Acanthocytosis is found to be associated with at least three hereditary neurological disorders that are generally referred to as neuroacanthocytosis. Abetalipoproteinaemia is an autosomal recessive condition, characterised by absence of serum apolipoprotein B containing lipoproteins leading to fat intolerance and fat-soluble vitamin deficiency. This results in a progressive spinocerebellar ataxia with peripheral neuropathy and retinitis pigmentosa. Chorea-acanthocytosis is also an autosomal recessive condition and is characterised by chorea, orofaciolingual dyskinesia, dysphagia, dysarthria, areflexia, seizures and dementia. Some of its features, including choreic movements, peripheral neuropathy with areflexia, elevated serum creatine kinase levels and myopathy are shared by another form of neuroacanthocytosis, McLeod syndrome. Patients affected by this X-linked disorder also show abnormal expression of Kell blood group antigens and a permanent haemolytic state. In addition to these cases, acanthocytosis is occasionally associated with other neurological disorders, such as Hallervorden-Spatz disease. For each of the neuroacanthocytosis syndromes we review the main clinical features and their molecular bases. The recent molecular genetics findings are the first step towards the understanding of the pathogenetic mechanisms and eventually the search for effective treatments.

AB - The term acanthocytosis is derived from the Greek for "thorn" and is used to describe a peculiar spiky appearance of erythrocytes. Acanthocytosis is found to be associated with at least three hereditary neurological disorders that are generally referred to as neuroacanthocytosis. Abetalipoproteinaemia is an autosomal recessive condition, characterised by absence of serum apolipoprotein B containing lipoproteins leading to fat intolerance and fat-soluble vitamin deficiency. This results in a progressive spinocerebellar ataxia with peripheral neuropathy and retinitis pigmentosa. Chorea-acanthocytosis is also an autosomal recessive condition and is characterised by chorea, orofaciolingual dyskinesia, dysphagia, dysarthria, areflexia, seizures and dementia. Some of its features, including choreic movements, peripheral neuropathy with areflexia, elevated serum creatine kinase levels and myopathy are shared by another form of neuroacanthocytosis, McLeod syndrome. Patients affected by this X-linked disorder also show abnormal expression of Kell blood group antigens and a permanent haemolytic state. In addition to these cases, acanthocytosis is occasionally associated with other neurological disorders, such as Hallervorden-Spatz disease. For each of the neuroacanthocytosis syndromes we review the main clinical features and their molecular bases. The recent molecular genetics findings are the first step towards the understanding of the pathogenetic mechanisms and eventually the search for effective treatments.

KW - Abetalipoproteinaemia

KW - Acanthocytosis

KW - Chorea

KW - McLeod syndrome

KW - Neuroacanthocytosis

UR - http://www.scopus.com/inward/record.url?scp=0036375439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036375439&partnerID=8YFLogxK

U2 - 10.1007/s00109-002-0349-z

DO - 10.1007/s00109-002-0349-z

M3 - Article

C2 - 12185448

AN - SCOPUS:0036375439

VL - 80

SP - 475

EP - 491

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 8

ER -